Heather M Dawson, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 14804 Edgewood St, Rosedale, NY 11422 Phone: 718-938-7238 |
Cherry Bryan Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 24602 135th Rd, Rosedale, NY 11422 Phone: 718-490-5297 |
Mr. William Gifford, L.C.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 24319 145th Ave, Rosedale, NY 11422 Phone: 718-712-4534 Fax: 718-712-2215 |
Stecia Pyrame Assad, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 253-28 149th Rd., Rosedale, NY 11422 Phone: 516-322-4869 |
Ms. Marie E. Austin, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 24937 147th Rd, Rosedale, NY 11422 Phone: 718-309-6655 |
Mr. Claudel Ariste, LCSW-R Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 25314 Craft Ave, Rosedale, NY 11422 Phone: 917-597-5028 |
Dina Tzipora Leff Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 24008 135th Ave, Rosedale, NY 11422 Phone: 347-728-6771 |
Marcia Williams-young, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 25748 149th Ave, Rosedale, NY 11422 Phone: 917-545-3710 |
Mr. Michael Clerry Omezi, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 24025 143rd Ave, Rosedale, NY 11422 Phone: 347-866-2267 Fax: 718-949-2004 |
Dr. Terry S Audate, LCSW-R Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 23318 130th Ave, Rosedale, NY 11422 Phone: 646-423-1286 |
News Archive
In this interview, Dr Harmut Schafer introduces the work being done at the Phenome Center in Birmingham, on metabolic phenotyping using NMR.
After recently announcing success in eliminating melanoma metastasis in laboratory experiments, scientists at Virginia Commonwealth University Massey Cancer Center have made another important discovery in understanding the process by which the gene mda-9/syntenin contributes to metastasis in melanoma (the spread of skin cancer) and possibly a variety of other cancers.
Dyax Corp. announced the publication of a first-ever comprehensive examination of the economic burden associated with the treatment of acute attacks and chronic management of hereditary angioedema (HAE). The results, published today in the Annals of Allergy, Asthma, and Immunology, bring to light the substantial direct and indirect medical costs of the disease on patients, payers and society. The economic study is one component of a larger survey-based Burden of Illness (BOI) study which assessed both the economic and humanistic burden of HAE.
4SC AG, a drug discovery and development company, today announced that the first patient has been dosed in the Phase I/II SHORE study with the oral pan-histone deacetylase (HDAC) inhibitor resminostat as a second-line treatment for patients with advanced and metastatic colorectal KRAS-mutant cancer.
› Verified 9 days ago